Interview, Fireside Chat
Inside Varda’s Space Factory | Delian Asparouhov, Founders Fund & Varda
- Space activity intensity is projected to increase annually, with a launch or landing anticipated at every board meeting this year, occurring between meetings next year, and multiple events per meeting by the end of the following year, potentially resulting in monthly or weekly re-entries visible over southern Australia.
- By the end of the year, four launch and landing missions are expected to generate tens of millions in revenue, while future operations aim to bring re-entering spacecraft back to the United States.
- Regulatory hurdles are expected to keep capital costs significantly higher for physical space companies compared to AI firms, though the FAA is adapting to high traffic via permanent NOTAM areas, and commercial flights may face longer durations due to avoided rocket corridors, with re-entry flight corridors potentially becoming the norm.
- The company plans to open a dedicated pharmaceutical lab approximately three minutes from its current headquarters and anticipates a facility split roughly between "half cement plant, half Space Force" given the proximity of a cement plant and the Space Systems Command to its site.
- Biological research suggests that 1g training in a Jupiter or floating environment could prepare humans to withstand 6g, whereas humans born on the Moon or Mars may be unable to return to Earth due to bodily collapse under 1g gravity, as the current body cannot withstand microgravity without centrifugal ships.
- Political risks involving the stranded astronauts are attributed to the Biden administration rejecting an early return offer to avoid providing a political win to SpaceX over Boeing, leading to indefinite stays and a narrative shift confirming they could have returned earlier.
- The Boeing Starliner program is viewed as severely delayed with unfixed thruster issues from prior tests, resulting in a decision to de-orbit the vehicle without the astronauts and raising concerns about the potential loss of an astronaut in space.
- The launch market includes competitors like Rocket Lab, Blue Origin, Firefly, and Stoke Aerospace, while Relativity Space is expected to have been near bankruptcy before Eric Schmidt's entry, a transition described as non-trivial given his background and age.
- Regulatory spectrum issues may force American companies to seek licenses in Germany, while the FCC is working to ease licensing, and the FAA is incorporating feedback into next-generation re-entry regulations.
- Defense tech expectations predict a power law outcome where only "one Anduril-like company" and perhaps one other will succeed among many, with 47 of the top 50 defense tech logos likely becoming irrelevant within 15 years, while new teams are forming under the Trump administration to address hypersonic and nuclear deficiencies.
- Venture capital strategy is shifting toward larger check sizes, with a target average of $7-$8 million and median increases over the next five years to achieve returns difficult to generate with small seed checks in a constrained pipeline.
- Investment focus is expected to move away from a heavy bias toward aerospace and defense to identify trends important five years from today, with a belief that only one in 1,000 founders matters, favoring a high-touch approach with the top 30 candidates over broad seeding.
- Top early-stage investors with successful tracks typically possess significant operational backgrounds, and the speaker plans to increase Series B involvement, recently leading a $45 million round, while expecting winners like Ramp to exceed previous valuations and Sword Health to thrive with Fortune 500 clients.
- Personal life changes, including the birth of a child on December 5th (five days after the speaker's 30th birthday), will drive a hyper-focused work strategy to maximize family time, reducing social engagements and shifting perspective toward long-term building and future generations.